medical device investing AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study
pharmaceutical investing ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872
Quimbaya Gold Starts Drilling at Tahami South, Testing Undrilled Gold System Beside Aris' Segovia Mine